オプションチェーンは、Bionomicsの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Bionomicsの市場センチメントを評価します。.

Bionomics (NASDAQ:BNOX) 株価情報, オプションチェーン

Bionomics

Bionomics Ltd is a clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.

Bionomics Limited - American Depository Shares

Bionomics Ltd

WIIM

Hyster-Yale shares are trading lower after the company reported worse-than-expected Q3 financial results. The company also issued expectations for FY25 revenues to be lower than 2024 and for operating profit and net income to decline significantly.

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains Brookfield Asset Mgmt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAM#NYSE">BAM</a>) with a Underperform and raises the price target from $44 to $49.

News

Price Target

Analyst Ratings

Keefe, Bruyette & Woods Maintains Underperform on Brookfield Asset Mgmt, Raises Price Target to $49

JP Morgan analyst Kenneth Worthington maintains Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) with a Neutral and lowers the price target from $22 to $21.

JP Morgan Maintains Neutral on Franklin Resources, Lowers Price Target to $21

UFPT

UFP Technologies shares are trading higher after the company reported better-than-expected Q3 financial results.

Blink Charging Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading higher on Tuesday.</a>
Today, the company has unveiled the creation of a Special Purpose Vehicle (SPV) designed to expand EV charging infrastructure<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41745007/blink-to-establish-a-100-million-special-purpose-vehicle-to-drive-electric-vehicle-charger-investm" rel="noreferrer noopener"> in the U.K. and beyond.</a>
The SPV aims to raise an initial £100 million ($130.10 million), offering investors the chance to capitalize on the rapidly growing EV infrastructure market.
To kick off the project, Blink has partnered with Axxeltrova Capital, a private equity firm focused on digital infrastructure, renewable energy, and sustainable investments. This makes it the SPV&#8217;s first funding partner.
&#8220;While we are in the early stages and agreements are still being formalized, the potential for growth in the EV sector is unmistakable,&#8221; said Mike Battaglia, CEO-Elect of Blink Charging.
&#8220;We invite other investors to join us in this exciting opportunity to shape the future of electric mobility.&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41748807/thomson-reuters-q3-earnings-legal-corporate-segments-enjoy-revenue-boost-as-ceo-highlights-ai-inves" rel="noreferrer noopener">Thomson Reuters Q3 Earnings: Legal, Corporate Segments Enjoy Revenue Boost As CEO Highlights AI Investment</a>
The SPV&#8217;s structure is designed to attract further investments, enabling Blink to deploy significant capital to expand accessible charging networks.
The SPV targets projects eligible for subsidies through the UK&#8217;s Local Electric Vehicle Infrastructure (LEVI) funding.
Recently, the firm disclosed that it has received a nearly $2 million grant from the Illinois&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/g41624237/blink-charging-awarded-2-million-grant-to-provide-ev-chargers-for-state-of-illinois" rel="noreferrer noopener">Environmental Protection Agency</a>.
This funding will enable Blink to own and operate EV chargers in the state of Illinois, facilitating public charging solutions for employees, residents, and visitors.
Under this grant, the Illinois EPA will cover part of the eligible expenses for new commercial-grade DC Fast Chargers and Alternating Current Level 2 charging stations to be installed at publicly accessible locations throughout Illinois.
Once completed, the project will feature 15 new Blink charging stations across five sites in Illinois, including 10 DC fast chargers with 180kW capacity and five Dual Port Level 2 stations (10 ports total). Blink is contributing a 30% cost share to the program.
Price Action:&nbsp;BLNK shares are up 2.99%&nbsp;at&nbsp;$2.07&nbsp;at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41631517/blink-to-deploy-15-new-ev-charging-stations-in-illinois-backed-by-2-million-state-grant" target="_blank" rel="noreferrer noopener">Blink To Deploy 15 New EV Charging Stations In Illinois, Backed By $2 Million State Grant</a></li>
</ul>

Equities

Markets

Movers

General

BLNK

What's Going On With Blink Charging Stock Tuesday?

Financial giants have made a conspicuous bearish move on CrowdStrike Holdings. Our analysis of options history for CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) revealed 19 unusual trades.
Delving into the details, we found 26% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we spotted, 11 were puts, with a value of $449,009, and 8 were calls, valued at $674,910.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $185.0 and $340.0 for CrowdStrike Holdings, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for CrowdStrike Holdings's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across CrowdStrike Holdings's significant trades, within a strike price range of $185.0 to $340.0, over the past month.
<h3>CrowdStrike Holdings Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730823366_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$120.3</td>
<td>$118.25</td>
<td>$118.25</td>
<td>$185.00</td>
<td>$260.1K</td>
<td style="text-align: right;">36</td>
<td style="text-align: right;">22</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$136.55</td>
<td>$126.65</td>
<td>$130.63</td>
<td>$220.00</td>
<td>$130.5K</td>
<td style="text-align: right;">112</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$81.8</td>
<td>$80.8</td>
<td>$81.8</td>
<td>$250.00</td>
<td>$81.8K</td>
<td style="text-align: right;">57</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$37.55</td>
<td>$37.25</td>
<td>$37.55</td>
<td>$310.00</td>
<td>$75.1K</td>
<td style="text-align: right;">545</td>
<td style="text-align: right;">20</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$33.8</td>
<td>$33.75</td>
<td>$33.8</td>
<td>$310.00</td>
<td>$67.6K</td>
<td style="text-align: right;">646</td>
<td style="text-align: right;">21</td>
</tr>
</tbody>
</table>

<h3>About CrowdStrike Holdings</h3>
CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.
Following our analysis of the options activities associated with CrowdStrike Holdings, we pivot to a closer look at the company's own performance.
<h3>CrowdStrike Holdings's Current Market Status</h3>
<ul>
<li>With a volume of 428,874, the price of CRWD is up 0.92% at $301.62. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 21 days.</li>
</ul>
<h3>Expert Opinions on CrowdStrike Holdings</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $342.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Exane BNP Paribas has revised its rating downward to Neutral, adjusting the price target to $285. 
&#x2A; An analyst from JMP Securities downgraded its action to Market Outperform with a price target of $400. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for CrowdStrike Holdings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

CRWD

This Is What Whales Are Betting On CrowdStrike Holdings

Yum! Brands shares are trading higher. The company reported Q3 financial results.

Whales with a lot of money to spend have taken a noticeably bearish stance on PDD Holdings.
Looking at options history for PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) we detected 37 trades.
If we consider the specifics of each trade, it is accurate to state that 35% of the investors opened trades with bullish expectations and 54% with bearish.
From the overall spotted trades, 11 are puts, for a total amount of $1,051,483 and 26, calls, for a total amount of $2,542,190.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $110.0 and $190.0 for PDD Holdings, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for PDD Holdings's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across PDD Holdings's significant trades, within a strike price range of $110.0 to $190.0, over the past month.
<h3>PDD Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730823361_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$6.05</td>
<td>$5.85</td>
<td>$5.85</td>
<td>$155.00</td>
<td>$818.9K</td>
<td>1.9K</td>
<td>1.4K</td>
</tr>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$22.65</td>
<td>$22.6</td>
<td>$22.64</td>
<td>$135.00</td>
<td>$221.6K</td>
<td>2.5K</td>
<td>189</td>
</tr>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$22.6</td>
<td>$22.55</td>
<td>$22.62</td>
<td>$135.00</td>
<td>$203.3K</td>
<td>2.5K</td>
<td>91</td>
</tr>
<tr>
<td>PDD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$39.65</td>
<td>$38.8</td>
<td>$39.35</td>
<td>$155.00</td>
<td>$196.7K</td>
<td>362</td>
<td>50</td>
</tr>
<tr>
<td>PDD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$35.6</td>
<td>$34.85</td>
<td>$35.4</td>
<td>$150.00</td>
<td>$177.0K</td>
<td>1.3K</td>
<td>50</td>
</tr>
</tbody>
</table>

<h3>About PDD Holdings</h3>
PDD Holdings is a multinational commerce group that owns and operates a portfolio of businesses. PDD aims to bring more businesses and people into the digital economy so that local communities and small businesses can benefit from the increased productivity and new opportunities. PDD has built a network of sourcing, logistics, and fulfillment capabilities that support its underlying businesses.
Following our analysis of the options activities associated with PDD Holdings, we pivot to a closer look at the company's own performance.
<h3>PDD Holdings's Current Market Status</h3>
<ul>
<li>With a volume of 2,881,166, the price of PDD is up 0.27% at $122.64. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 21 days.</li>
</ul>
<h3>What The Experts Say On PDD Holdings</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $224.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Macquarie upgraded its action to Outperform with a price target of $224. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for PDD Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Decoding PDD Holdings's Options Activity: What's the Big Picture?

RBC Capital analyst Brian Abrahams reiterates BioCryst Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCRX#NASDAQ">BCRX</a>) with a Outperform and maintains $10 price target.

Reiteration

BCRX

RBC Capital Reiterates Outperform on BioCryst Pharma, Maintains $10 Price Target

Whales with a lot of money to spend have taken a noticeably bearish stance on Newmont.
Looking at options history for Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 16% of the investors opened trades with bullish expectations and 75% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $713,310 and 5, calls, for a total amount of $463,240.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $60.0 for Newmont, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Newmont options trades today is 5097.0 with a total volume of 2,750.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Newmont's big money trades within a strike price range of $30.0 to $60.0 over the last 30 days.
<h3>Newmont Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730823356_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$12.5</td>
<td>$12.4</td>
<td>$12.5</td>
<td>$57.50</td>
<td>$352.5K</td>
<td>374</td>
<td style="text-align: right;">283</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$13.5</td>
<td>$13.3</td>
<td>$13.44</td>
<td>$35.00</td>
<td>$295.6K</td>
<td>5.0K</td>
<td style="text-align: right;">220</td>
</tr>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$14.85</td>
<td>$14.75</td>
<td>$14.85</td>
<td>$60.00</td>
<td>$142.5K</td>
<td>2</td>
<td style="text-align: right;">97</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$18.85</td>
<td>$18.45</td>
<td>$18.7</td>
<td>$30.00</td>
<td>$56.1K</td>
<td>38</td>
<td style="text-align: right;">30</td>
</tr>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$12.5</td>
<td>$12.4</td>
<td>$12.5</td>
<td>$57.50</td>
<td>$55.0K</td>
<td>374</td>
<td style="text-align: right;">328</td>
</tr>
</tbody>
</table>

<h3>About Newmont</h3>
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 5.5 million ounces of gold in 2024 from its core mines and 6.8 million in total. It is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at the end of December 2023.
Following our analysis of the options activities associated with Newmont, we pivot to a closer look at the company's own performance.
<h3>Newmont's Current Market Status</h3>
<ul>
<li>Trading volume stands at 1,499,891, with NEM's price up by 0.2%, positioned at $45.85.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 107 days.</li>
</ul>
<h3>Expert Opinions on Newmont</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $59.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from UBS downgraded its rating to Neutral, setting a price target of $54. 
&#x2A; An analyst from Raymond James has decided to maintain their Outperform rating on Newmont, which currently sits at a price target of $66. 
&#x2A; Reflecting concerns, an analyst from Scotiabank lowers its rating to Sector Perform with a new price target of $55. 
&#x2A; An analyst from RBC Capital persists with their Sector Perform rating on Newmont, maintaining a target price of $53. 
&#x2A; An analyst from UBS persists with their Buy rating on Newmont, maintaining a target price of $67. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Newmont options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Newmont Unusual Options Activity For November 05

ARIS

Aris Water Solutions shares are trading higher after the company reported better-than-expected Q3 financial results.

JP Morgan analyst Cory Carpenter maintains EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) with a Overweight and lowers the price target from $34 to $28.

EVER

JP Morgan Maintains Overweight on EverQuote, Lowers Price Target to $28

B. Riley Securities analyst Zach Cummins maintains QuinStreet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNST#NASDAQ">QNST</a>) with a Buy and raises the price target from $24 to $32.

QNST

B. Riley Securities Maintains Buy on QuinStreet, Raises Price Target to $32

Payoneer Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYO#NASDAQ">PAYO</a>) reported third-quarter financial results before the market open on Tuesday. Here&#8217;s a <a href="https://www.benzinga.com/pressreleases/24/11/b41741854/payoneer-reports-third-quarter-2024-financial-results">rundown of the report</a>.
<ul>
<li>Q3 Revenue: $248.27 million, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $225.48 million</li>
</ul>
<ul>
<li>Q3 EPS: 11 cents, versus estimates of 4 cents</li>
</ul>
Payoneer reported $1.4 billion&nbsp;of spend on Payoneer cards in the third quarter, up&nbsp;41%&nbsp;year-over-year. The company also reported record quarterly volume, up 25% year-over-year. 
&#8220;Payoneer delivered record quarterly volume and revenue, and significant profitability in the&nbsp;third quarter.&nbsp;We are building a full-service financial stack for global cross-border SMBs and accelerating growth and profitability across our business,&#8221; said John Caplan, CEO of Payoneer.
&#8220;We are at the beginning of our growth trajectory and are focused on consistent execution to capture the opportunity ahead of us.&#8221;
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41746843/bond-market-fear-gauge-soars-to-1-year-high-ahead-of-us-election-results-bond-vigil">Bond Market Fear Gauge Soars To 1-Year High Ahead Of US Election Results: &#8216;Bond Vigilantes Have Been Voting Early&#8217;</a>
Outlook: Payoneer raised its full-year 2024 revenue guidance from a range of $920 million to $930 million to a new range of $950 million to $960 million, versus estimates of $928.71 million, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
The company also raised its full-year adjusted EBITDA expectations from a range of $225 million to $235 million to a new range of $255 million to $265 million. 
PAYO Price Action: <a href="http://benzinga.com/quote/payo">Payoneer shares</a> were up 16.8% at $9.95 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Earnings

Guidance

PAYO

Payoneer Stock Jumps On Q3 Earnings: The Details

ESLT

Elbit Systems shares are trading higher after the company announced that it was awarded a follow-on contract of approximately $127 million to supply Iron Fist Active Protection Systems to General Dynamics Ordnance and Tactical Systems for upgrades to the U.S. Army's Bradley M2A4E1 Infantry Fighting Vehicles.

B. Riley Securities analyst Alex Rygiel reiterates MasTec (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTZ#NYSE">MTZ</a>) with a Buy and raises the price target from $151 to $166.

B. Riley Securities Reiterates Buy on MasTec, Raises Price Target to $166

JP Morgan analyst Matthew Boss maintains Bowlero (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOWL#NYSE">BOWL</a>) with a Overweight and lowers the price target from $16 to $15.

BOWL

JP Morgan Maintains Overweight on Bowlero, Lowers Price Target to $15

RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHE#NYSE">CHE</a>) with a Outperform and lowers the price target from $697 to $633.

RBC Capital Maintains Outperform on Chemed, Lowers Price Target to $633

Dogecoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) single-day 11% surge has sparked speculation in the cryptocurrency community if a strong bullish run is possible in case of a <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41744889/kamala-harris-backed-by-polymarkets-top-3-all-time-traders-but-two-of-them-have-hedged-the">Trump election win</a>.
What Happened: Crypto chart analyst Ali Martinez flagged a &#8220;Sell&#8221; signal on Dogecoin's 4-hour chart, forecasting a potential correction to $0.161 or $0.156. <a href="https://twitter.com/ali_charts/status/1853448113719247312">According to</a> Ali Martinez, Dogecoin's user base continues to grow, with over 35,000 new DOGE addresses being created daily.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The TD Sequential presents a sell signal on the <a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> <a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> 4-hour chart, anticipating a correction to $0.161 or $0.156! <a href="https://t.co/q8CRhYSZR4">pic.twitter.com/q8CRhYSZR4</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1853737569529331972?ref_src=twsrc%5Etfw">November 5, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Unipcs expects Dogecoin could go "parabolic" if Donald Trump wins the election, foreseeing gains for both DOGE and the similarly named meme asset, &#8216;Department of Government Efficiency&#8217; (D.O.G.E.). He <a href="https://x.com/theunipcs/status/1853757117766705585">likened</a> their current state to "underwater beachballs waiting to explode."
Other commentators in the crypto community <a href="https://x.com/MikybullCrypto/status/1853732020481913019">pointed out</a> Dogecoin&#8217;s first golden cross since Q4 2020 and strength in <a href="https://x.com/AltcoinSherpa/status/1853753655578575014">chart patterns</a>. 
Trader Rekt Capital pointed out that Dogecoin recently retested its May highs as new support, suggesting the coin could eventually revisit the $0.20 level.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> Dogecoin has also most recently successfully retested the May 2024 highs as new support (blue) Overall, continued stability above blue will continue to position DOGE for a move via the orange pathway to revisit the $0.20 highs (black) over time<a href="https://twitter.com/hashtag/DOGE?src=hash&amp;ref_src=twsrc%5Etfw">#DOGE</a> <a href="https://twitter.com/hashtag/Crypto?src=hash&amp;ref_src=twsrc%5Etfw">#Crypto</a> <a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> <a href="https://t.co/CkqCTH6Dms">https://t.co/CkqCTH6Dms</a> <a href="https://t.co/oEKk87uvu7">pic.twitter.com/oEKk87uvu7</a>
&mdash; Rekt Capital (@rektcapital) <a href="https://twitter.com/rektcapital/status/1853803996068089934?ref_src=twsrc%5Etfw">November 5, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41699095/dogecoin-set-for-parabolic-bull-run-in-november-says-analyst-keep-an-eye-out-for-a-sustain">Dogecoin Set For &#8216;Parabolic Bull Run&#8217; In November, Says Analyst: &#8216;Keep An Eye Out For A Sustained Close&#8217; Above This Level</a>
IntoTheBlock data shows large transaction volumes up by 27.2%, with daily active addresses increasing by 13.4% and major transactions over $100,000 rising from 373 to 586 in just one day. Exchanges netflows are down by 173.2%.
What&#8217;s Next: The influence of meme coins is expected to be thoroughly explored at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41688358/dogecoin-dips-but-traders-identify-this-critical-support-zone-for-a-bounce">Dogecoin Dips But Traders Identify This Critical Support Zone For A Bounce</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

Dogecoin Skyrockets 11%: What Is Going On?

B. Riley Securities analyst Mayank Mamtani maintains Madrigal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDGL#NASDAQ">MDGL</a>) with a Neutral and raises the price target from $194 to $236.

MDGL

B. Riley Securities Maintains Neutral on Madrigal Pharmaceuticals, Raises Price Target to $236

Bionomics (BNOX) has released an update. Bionomics Limited, an Australian biotech firm, has entered into a Securities Purchase Agreement with selec...

Bionomics Secures Growth Through Strategic Sale

In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Bionomics (BNOX – Research Report), with a price targe...

Bionomics Secures Solid Financial Runway with $70M Financing Ahead of Phase 3 SAD Study, Earns 'Buy' Rating

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into this morning and we have all of the hottest news worth checking out on Thursday!



Moving stocks this morning are an acquisition deal, a clinical trial launch, earnings reports and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Chuy&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/chuy-stock-quote/">CHUY</a>) stock is rocketing more than 46% on a <a href="https://www.nasdaq.com/press-release/darden-restaurants-acquire-chuys-holdings-inc-approximately-605-million-transaction">$605 million acquisition deal</a>.</li>



<li>Onconetix (NASDAQ:<a href="https://investorplace.com/stock-quotes/onco-stock-quote/">ONCO</a>) shares are soaring over 43% alongside heavy pre-market trading.</li>



<li>Apollomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/aplm-stock-quote/">APLM</a>) stock is surging more than 25% with strong early morning trading.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) shares are rising over 23% as it <a href="https://www.nasdaq.com/press-release/bionomics-initiates-affirm-1-phase-3-clinical-trial-bnc210-social-anxiety-disorder">kicks off a Phase 3 clinical trial</a>.</li>



<li>Big Tree Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/dsy-stock-quote/">DSY</a>) stock is increasing more than 18% with strong pre-market trading.</li>



<li>ZimVie (NASDAQ:<a href="https://investorplace.com/stock-quotes/zimv-stock-quote/">ZIMV</a>) shares are heading over 13% higher without any clear news on Thursday morning.</li>



<li>SAI.TECH Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/sai-stock-quote/">SAI</a>) stock is gaining more than 12% on a <a href="https://www.globenewswire.com/news-release/2024/07/18/2914992/0/en/SAI-TECH-Global-Corporation-Announces-Share-Repurchase-Program.html">share repurchase program</a>.</li>



<li>MultiMetaVerse (NASDAQ:<a href="https://investorplace.com/stock-quotes/mmv-stock-quote/">MMV</a>) shares are climbing over 11% as it continues a recent rally.</li>



<li>Psyence Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbm-stock-quote/">PBM</a>) stock is jumping more than 10% despite a lack of news today.</li>



<li>XWELL (NASDAQ:<a href="https://investorplace.com/stock-quotes/xwel-stock-quote/">XWEL</a>) shares are up over 10% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Leslies (NASDAQ:<a href="https://investorplace.com/stock-quotes/lesl-stock-quote/">LESL</a>) stock is diving more than 21% on <a href="https://www.nasdaq.com/press-release/leslies-inc-announces-preliminary-third-quarter-fiscal-2024-financial-results-and">preliminary earnings and guidance</a>.</li>



<li>Aptevo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/">APVO</a>) shares are rumbling over 13% after a massive rally yesterday.</li>



<li>Domino&rsquo;s Pizza (NYSE:<a href="https://investorplace.com/stock-quotes/dpz-stock-quote/">DPZ</a>) stock is sliding more than 13% with the release of its <a href="https://ir.dominos.com/static-files/68ecdbfc-bd1c-486a-a574-d6f54b7e5132">Q2 earnings report</a>.</li>



<li>CBL International (NASDAQ:<a href="https://investorplace.com/stock-quotes/banl-stock-quote/">BANL</a>) shares are taking an over 12% beating on Thursday morning as it retreats from a rally yesterday.</li>



<li>WiMi Hologram Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/wimi-stock-quote/">WIMI</a>) stock is dropping close to 12% after an unexpected rally yesterday.</li>



<li>Beyond Meat (NASDAQ:<a href="https://investorplace.com/stock-quotes/bynd-stock-quote/">BYND</a>) shares are falling more than 11% on <a href="https://www.wsj.com/articles/beyond-meat-engages-bondholders-for-restructuring-talks-7de6b8ae">restructuring talks with bondholders</a>.</li>



<li>American Rebel (NASDAQ:<a href="https://investorplace.com/stock-quotes/areb-stock-quote/">AREB</a>) stock is decreasing over 11% this morning after rallying on Wednesday.</li>



<li>Aditxt (NASDAQ:<a href="https://investorplace.com/stock-quotes/adtx-stock-quote/">ADTX</a>) shares are slipping more than 10% <a href="https://investorplace.com/2024/07/why-is-aditxt-adtx-stock-up-72-today/">following a rally yesterday</a>.</li>



<li>Stardust Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/sdst-stock-quote/">SDST</a>) stock is dipping over 10% <a href="https://investorplace.com/2024/07/stardust-power-sdst-stock-pops-140-days-after-debut-what-to-know/">after a surprise rally yesterday</a>.</li>



<li>GRI Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/gri-stock-quote/">GRI</a>) shares close out our pre-market stock movers down more than 9%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-july-18th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Analyst Joseph Pantginis of H.C. Wainwright reiterated a Buy rating on Bionomics (BNOX – Research Report), retaining the price target of $8.00. Jos...

Buy Rating Affirmed on Bionomics as BNC210 Enters Critical Phase 3 Trial for Social Anxiety Disorder

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic on Friday as we check out all of the latest stories affecting shares on the last day of trading this week!



Moving stocks this morning are a Maui fire settlement report, a reverse stock split notice, earnings reports and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Serve Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/serv-stock-quote/">SERV</a>) stock is rocketing more than 68% with heavy trading after announcing <a href="https://www.nasdaq.com/press-release/presentation-times-and-schedule-participating-companies-now-posted-conference-website">a presentation yesterday</a>.</li>



<li>60 Degrees (NASDAQ:<a href="https://investorplace.com/stock-quotes/sxtp-stock-quote/">SXTP</a>) shares are soaring over 37% alongside strong early morning trading.</li>



<li>Hawaiian Electric Industries (NYSE:<a href="https://investorplace.com/stock-quotes/he-stock-quote/">HE</a>) stock is surging more than 37% on reports it included in the <a href="https://finance.yahoo.com/news/hawaiian-electric-among-firms-4-212211492.html">Maui fire settlement</a>.</li>



<li>Power REIT (NYSEMKT:<a href="https://investorplace.com/stock-quotes/pw-stock-quote/">PW</a>) shares are increasing over 23% without any apparent news.</li>



<li>Safe &amp; Green Development (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgd-stock-quote/">SGD</a>) stock is gaining more than 23% with strong pre-market trading.</li>



<li>Novo Integrated Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvos-stock-quote/">NVOS</a>) shares are rising over 22% on a <a href="https://www.businesswire.com/news/home/20240718621664/en/Novo-Integrated-Sciences-Receives-Commencement-of-Disbursement-Notice-for-SBLC-Leasing-and-Monetizing-Program">disbursement funds notice</a>.</li>



<li>Unicycive Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/uncy-stock-quote/">UNCY</a>) stock is climbing more than 15% despite a lack of news this morning.</li>



<li>Talphera (NASDAQ:<a href="https://investorplace.com/stock-quotes/tlph-stock-quote/">TLPH</a>) shares are heading over 13% higher without any clear news to report.</li>



<li>TuanChe (NASDAQ:<a href="https://investorplace.com/stock-quotes/tc-stock-quote/">TC</a>) stock is jumping close to 13% on Friday morning.</li>



<li>Sobr Safe (NASDAQ:<a href="https://investorplace.com/stock-quotes/sobr-stock-quote/">SOBR</a>) shares are up more than 12% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Nauticus Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) stock is diving over 19% after <a href="https://www.prnewswire.com/news-releases/nauticus-robotics-announces-transformative-1-for-36-reverse-stock-split-302201004.html">announcing a reverse stock split</a>.</li>



<li>SunPower (NASDAQ:<a href="https://investorplace.com/stock-quotes/spwr-stock-quote/">SPWR</a>) shares are tumbling more than 17% after <a href="https://finance.yahoo.com/news/sunpower-plunges-halting-solar-installs-180816388.html">halting some of its operations</a>.</li>



<li>WaveDancer (NASDAQ:<a href="https://investorplace.com/stock-quotes/wavd-stock-quote/">WAVD</a>) stock is taking a nearly 14% beating on Friday morning.</li>



<li>CrowdStrike (NASDAQ:<a href="https://investorplace.com/stock-quotes/crwd-stock-quote/">CRWD</a>) shares are sliding over 13% <a href="https://www.cnbc.com/2024/07/19/crowdstrike-suffers-major-outage-affecting-businesses-around-the-world.html">alongside outages and issues</a>.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) stock is dropping more than 11% <a href="https://www.nasdaq.com/press-release/bionomics-initiates-affirm-1-phase-3-clinical-trial-bnc210-social-anxiety-disorder">following clinical trial results yesterday</a>.</li>



<li>Scholastic (NASDAQ:<a href="https://investorplace.com/stock-quotes/schl-stock-quote/">SCHL</a>) shares are decreasing over 11% with its <a href="https://www.benzinga.com/news/earnings/24/07/39849856/scholastic-shares-fall-after-worse-than-expected-q4-results-details">fiscal Q4 earnings report</a>.</li>



<li>Salarius Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/slrx-stock-quote/">SLRX</a>) stock is falling more than 10% after a major rally yesterday.</li>



<li>HighPeak Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/hpkew-stock-quote/">HPKEW</a>) shares are slipping over 10% this morning.</li>



<li>Super League Enterprise (NASDAQ:<a href="https://investorplace.com/stock-quotes/sle-stock-quote/">SLE</a>) stock is dipping almost 10% today.</li>



<li>CytoMed Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/gdtc-stock-quote/">GDTC</a>) shares are down more than 9%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-july-19th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news happening this morning!



Moving stocks this morning are clinical trial updates, earnings reports and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Primech (NASDAQ:<a href="https://investorplace.com/stock-quotes/pmec-stock-quote/">PMEC</a>) stock is rocketing close to 90% alongside heavy pre-market trading.</li>



<li>Nuzee (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuze-stock-quote/">NUZE</a>) shares are soaring more than 69% with strong early morning trading.</li>



<li>Heramba Electric (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PITA#NASDAQ">PITA</a>) stock is surging over 43% with increasing trading activity this morning.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) shares are gaining more than 31% on a <a href="https://www.nasdaq.com/press-release/bionomics-announces-successful-end-phase-2-meeting-fda-development-bnc210-post">Phase 2 clinical trial meeting</a>.</li>



<li>Powell Industries (NASDAQ:<a href="https://investorplace.com/stock-quotes/powl-stock-quote/">POWL</a>) stock is rising over 25% after <a href="https://finance.yahoo.com/news/powell-industries-powl-q3-earnings-214005995.html">beating Q3 estimates</a>.</li>



<li>BIMI International Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/bimi-stock-quote/">BIMI</a>) shares are increasing more than 20% with strong early morning trading today.</li>



<li>DallasNews (NASDAQ:<a href="https://investorplace.com/stock-quotes/daln-stock-quote/">DALN</a>) stock is climbing over 18% with its <a href="https://investorplace.com/earning-results/2024/07/daln-stock-earnings-dallasnews-for-q2-of-2024/">Q2 earnings report</a>.</li>



<li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) shares are jumping more than 17% after <a href="https://finance.yahoo.com/news/faraday-future-regains-compliance-nasdaq-031500213.html">regaining listing compliance</a>.</li>



<li>GraniteShares 2x Long AMD Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/amdl-stock-quote/">AMDL</a>) stock is getting an over 17% boost this morning.</li>



<li>Talen Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/tln-stock-quote/">TLN</a>) shares are up more than 17% after <a href="https://www.nasdaq.com/press-release/talen-reports-pjm-auction-results-2025-2026-planning-year-2024-07-30">reporting PJM Auction Results</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>FibroGen (NASDAQ:<a href="https://investorplace.com/stock-quotes/fgen-stock-quote/">FGEN</a>) stock is plummeting over 44% on a <a href="https://www.nasdaq.com/press-release/fibrogen-announces-topline-results-two-late-stage-pamrevlumab-pancreatic-cancer">failed clinical trial</a>.</li>



<li>Macrogenics (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgnx-stock-quote/">MGNX</a>) shares are diving more than 26% as it <a href="https://www.nasdaq.com/press-release/macrogenics-provides-vobramitamab-duocarmazine-update-2024-07-30">discontinues a clinical trial</a>.</li>



<li>Jet AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/jtai-stock-quote/">JTAI</a>) stock is tumbling over 21% on an <a href="https://www.nasdaq.com/press-release/jetai-announces-expiration-and-successful-results-exchange-offer-and-consent">exchange offer for its warrants</a>.</li>



<li>Penumbra (NYSE:<a href="https://investorplace.com/stock-quotes/pen-stock-quote/">PEN</a>) shares are taking a more than 18% beating <a href="https://finance.yahoo.com/news/penumbra-pen-reports-q2-earnings-230019255.html">with its Q2 earnings report</a>.</li>



<li>Groupon (NASDAQ:<a href="https://investorplace.com/stock-quotes/grpn-stock-quote/">GRPN</a>) stock is sliding over 17% <a href="https://investorplace.com/earning-results/2024/07/grpn-stock-earnings-groupon-for-q2-of-2024/">on an EPS miss</a>.</li>



<li>Definitive Healthcare (NASDAQ:<a href="https://investorplace.com/stock-quotes/dh-stock-quote/">DH</a>) shares are falling more than 16% without any clear news this morning.</li>



<li>Netcapital (NASDAQ:<a href="https://investorplace.com/stock-quotes/ncpl-stock-quote/">NCPL</a>) stock is dropping over 16% after <a href="https://investorplace.com/earning-results/2024/07/ncpl-stock-earnings-netcapital-for-q4-of-2024/">missing estimates in fiscal 2024</a>.</li>



<li>O-I Glass (NYSE:<a href="https://investorplace.com/stock-quotes/oi-stock-quote/">OI</a>) shares are decreasing more than 15% <a href="https://www.stocktitan.net/news/OI/o-i-glass-reports-second-quarter-2024-71rm58wp8yg0.html">with its Q2 results</a>.</li>



<li>Lemonade (NYSE:<a href="https://investorplace.com/stock-quotes/lmnd-stock-quote/">LMND</a>) stock is slipping over 13% <a href="https://www.marketwatch.com/story/lemonades-stock-slides-14-after-posting-q2-loss-5e14bea8">alongside a weak guidance</a>.</li>



<li>Tivic Health Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/tivc-stock-quote/">TIVC</a>) shares close out our pre-market stock movers down 13% <a href="https://investorplace.com/2024/07/tivic-health-systems-tivc-stock-pops-another-39-july-29th/">after a rally yesterday</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-july-31st/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Bionomics (BNOX – Research Report) today and set a price target of $8.00. Josep...

Bionomics Poised for Phase 3 Success with BNC210 Following Favorable FDA Meeting: A Strong Buy Recommendation

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning!



Moving stocks this morning are earnings reports, a stock offering, a reverse stock split and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Digital Ally (NASDAQ:<a href="https://investorplace.com/stock-quotes/dgly-stock-quote/">DGLY</a>) stock is rocketing more than 107% alongside heavy pre-market trading.</li>



<li>Viracta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) shares are soaring over 53% with the <a href="https://www.nasdaq.com/press-release/viracta-therapeutics-reports-second-quarter-2024-financial-results-and-provides">release of its Q2 earnings report</a>.</li>



<li>Conduit Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) stock is surging more than 42% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318518494&amp;type=PDF&amp;symbol=CDT&amp;cdn=197541151657f71d6ed19abcc1e0e48e&amp;companyName=Conduit+Pharmaceuticals+Inc.&amp;formType=3&amp;formDescription=Initial+statement+of+beneficial+ownership+of+securities&amp;dateFiled=2024-08-13">an investment update</a>.</li>



<li>Nuburu (NYSEMKT:<a href="https://investorplace.com/stock-quotes/buru-stock-quote/">BURU</a>) shares are rising over 26% despite a lack of news this morning.</li>



<li>Jianzhi Education Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/jz-stock-quote/">JZ</a>) stock is gaining close to 19% even with a <a href="https://www.nasdaq.com/press-release/jianzhi-education-technology-group-company-limited-receives-nasdaq-notification-0">recent delisting notice</a>.</li>



<li>Edible Garden (NASDAQ:<a href="https://investorplace.com/stock-quotes/edbl-stock-quote/">EDBL</a>) shares are increasing more than 18% on <a href="https://www.nasdaq.com/press-release/edible-garden-reports-157-increase-gross-profit-fueled-year-over-year-growth-61-cut">strong Q2 earnings</a>.</li>



<li>Ucloudlink (NASDAQ:<a href="https://investorplace.com/stock-quotes/ucl-stock-quote/">UCL</a>) stock is heading over 16% higher with its <a href="https://www.nasdaq.com/press-release/ucloudlink-group-inc-announces-unaudited-second-quarter-2024-financial-results-2024">most recent earnings report</a>.</li>



<li>Vertex Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/vtnr-stock-quote/">VTNR</a>) shares are jumping 16% with strong early morning trading.</li>



<li>Serve Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/serv-stock-quote/">SERV</a>) stock is climbing more than 15% with its <a href="https://www.stocktitan.net/news/SERV/serve-robotics-announces-second-quarter-2024-wqwtqr037uv4.html">Q2 earnings report</a>.</li>



<li>Kamada (NASDAQ:<a href="https://investorplace.com/stock-quotes/kmda-stock-quote/">KMDA</a>) shares are up over 15% after posting <a href="https://www.nasdaq.com/press-release/kamada-reports-strong-second-quarter-and-first-half-2024-financial-results-year-over">positive Q2 earnings results</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>TC BioPharm (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcbp-stock-quote/">TCBP</a>) stock is crashing more than 42% after <a href="https://www.nasdaq.com/press-release/tc-biopharm-announces-pricing-20-registered-direct-offering-2024-08-13">pricing a registered direct offering</a>.</li>



<li>Surgepays (NASDAQ:<a href="https://investorplace.com/stock-quotes/surg-stock-quote/">SURG</a>) shares are plummeting over 26% after <a href="https://www.prnewswire.com/news-releases/surgepays-announces-second-quarter-2024-financial-results-302221503.html">reporting a Q2 loss</a>.</li>



<li>Arcadia Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/rkda-stock-quote/">RKDA</a>) stock is diving more than 16% after <a href="https://markets.businessinsider.com/news/stocks/rkda-stock-earnings-arcadia-biosciences-for-q2-of-2024-1033684150">missing Q2 EPS estimates</a>.</li>



<li>Ouster (NYSE:<a href="https://investorplace.com/stock-quotes/oust-stock-quote/">OUST</a>) shares are taking an over 16% beating on <a href="https://www.businesswire.com/news/home/20240813944318/en/Ouster-Reports-Strong-Revenue-and-Margins-for-Second-Quarter-2024">mixed Q2 earnings</a>.</li>



<li>QuickLogic (NASDAQ:<a href="https://investorplace.com/stock-quotes/quik-stock-quote/">QUIK</a>) stock is tumbling more than 16% with its <a href="https://www.prnewswire.com/news-releases/quicklogic-reports-41-year-over-year-revenue-growth-for-second-quarter-fiscal-2024-302221555.html">latest earnings release</a>.</li>



<li>Brinker International (NYSE:<a href="https://investorplace.com/stock-quotes/eat-stock-quote/">EAT</a>) shares are sliding over 16% after <a href="https://www.investing.com/news/stock-market-news/brinker-international-stock-tumbles-13-on-q4-earnings-miss-93CH-3570960">posting an earnings miss</a>.</li>



<li>Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) stock is falling more than 15% after <a href="https://www.stocktitan.net/news/PRTG/portage-biotech-announces-1-for-20-reverse-stock-sficaewojjpr.html">announcing a reverse stock split</a>.</li>



<li>Global E Online (NASDAQ:<a href="https://investorplace.com/stock-quotes/glbe-stock-quote/">GLBE</a>) shares are decreasing over 14% with its <a href="https://www.stocktitan.net/news/GLBE/global-e-reports-second-quarter-2024-1dq5hcfetvn1.html">Q2 earnings report</a>.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) stock is dropping more than 14% without any clear news this morning.</li>



<li>WISeKey (NASDAQ:<a href="https://investorplace.com/stock-quotes/wkey-stock-quote/">WKEY</a>) shares close out our pre-market stock movers down nearly 14% on a <a href="https://www.nasdaq.com/press-release/sealcoin-secures-50-million-investment-commitment-gem-digital-limited-through-0">new investment</a> <a href="https://www.nasdaq.com/press-release/wisekey-partners-venafi-post-quantum-encryption-services-2024-08-14">and partnership</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-aug-14th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

The latest announcement is out from Bionomics ( ($BNOX) ). On October 9, 2024, Aaron Weaver resigned from his position on the Board of Directors of...

Aaron Weaver Ends Tenure on Bionomics Board

Bionomics (BNOX) announced that it received a milestone payment of A$1M from Carina Biotech for BNC101, one of their partnered legacy oncology prog...

Bionomics receives A$1M milestone payment from Carina Biotech for BNC101

ADTX

AMDL

APLM

APVO

AREB

BANL

BIMI

BNOX

BURU

BYND

CHUY

DALN

DGLY

EDBL

FFIE

FGEN

GDTC

GLBE

GRPN

HPKEW

JTAI

KITT

KMDA

LESL

LMND

MGNX

NCPL

NUZE

NVOS

ONCO

OUST

PITA

PMEC

POWL

PRTG

QUIK

RKDA

SCHL

SDST

SERV

SLRX

SOBR

SPWR

SURG

SXTP

TCBP

TIVC

TLPH

UNCY

VIRX

VTNR

WAVD

WIMI

WKEY

XWEL

ZIMV

Press Releases

Bionomics Limited Announces Private Placement of up to $70.0 Million

Bionomics Initiates AFFIRM-1, a Phase 3 Clinical Trial with BNC210 for Social Anxiety Disorder

Bionomics to Provide a Corporate Update and Discuss End-of-Phase 2 Meeting Outcomes on the Development of BNC210 in PTSD on July 31, 2024

Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder

Bionomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Health Care

Bionomics Limited announces intention to re-domicile to the United States

Bionomics Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC

Bionomics to Present at the ThinkEquity Conference

Bionomics Receives Milestone Payment of AUS$1M from Carina Biotech for BNC101 Partnered Legacy Oncology Program

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

Apollomics

Bone Biologics

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Entero Therapeutics

Lipella Pharmaceuticals Inc. - Common Stock

Lipella Pharmaceuticals

Molecular Templates

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Palisade Bio

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharma

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

Revelation Biosciences, Inc. - Common Stock

Revelation Biosciences

Scinai Immunotherapeutics Ltd. - American Depositary Shares

Scinai Immunotherapeutics

Scorpius Holdings

Salarius Pharmaceuticals, Inc. - Common Stock

Salarius Pharmaceuticals

TC BioPharm (Holdings) plc - American Depositary Shares

TC BioPharm (Holdings)

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Theriva Biologics

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics

ZyVersa Therapeutics, Inc. - Common Stock

ZyVersa Therapeutics

HC Wainwright & Co.

Maxim Group

Evercore ISI Group

Loop Capital

Cantor Fitzgerald

Bionomics shares are trading higher after the company announced it secured an AUS$1 million milestone payment from Carina Biotech for its BNC101 oncology program, with the potential to earn up to AUS$118 million.

Comments

Bionomics

Bionomics (BNOX) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル